COMP <GO>
RCEL vs ANGO // FORWARD P/E MULTIPLE
Avita Medical Inc. (NASDAQ) VS. AngioDynamics Inc. (NASDAQ) • 15-METRIC TALLY: RCEL 3
— ANGO 6
■ METRIC PARITY
LAST: $16.71 (+1.27%) • MKT CAP: $516.8M
forward-pe
—
LAST: $12.35 (+1.81%) • MKT CAP: $519.4M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCEL VS. ANGO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RCEL | ANGO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 82.10% | 54.60% | +27.50 | RCEL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -23.40% | -11.60 | ANGO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.23% | 0.10% | -6.33 | ANGO | /fcf-yield <GO> |
| Operating Margin | -59.40% | -12.50% | -46.90 | ANGO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -11.50% | -48.50 | ANGO | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 9.50% | +2.00 | RCEL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | ANGO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.6 | 44.5 | +27.10 | RCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $516.8M | $519.4M | -$2.6M | ANGO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RCEL REV | ANGO REV | RCEL GROSS % | ANGO GROSS % | RCEL FCF | ANGO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $71.6M | $320.2M | 82.1% | 54.6% | -$32.2M | $508.0K |
| FY 2024 | $64.3M | $292.5M | 85.8% | 53.9% | -$58.1M | -$14.6M |
| FY 2023 | $50.1M | $303.9M | — | — | -$38.0M | -$28.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCEL // BETA —
ANGO // BETA —